Akorn announces two key executive appointments
News provided by
Share this article
Share this article
LAKE FOREST, Ill., May 10, 2021 /PRNewswire/ Akorn Operating Company LLC (Akorn), a leading specialty pharmaceutical company, announced two new executive appointments.
Beth Zelnick Kaufman has joined Akorn as the Executive Vice President, Chief Legal Officer and Corporate Secretary. Concurrently, Sandhya Goyal has joined Akorn as the Senior Vice President & Chief Scientific Officer. Both Beth and Sandhya report to Douglas Boothe, Akorn s President and Chief Executive Officer.
Ms. Goyal most recently was the Vice President of Research & Development for Cosette Pharmaceuticals (formerly G&W Labs) and will provide leadership to Akorn s Research & Development organization. Ms. Zelnick Kaufman will be leading Akorn s legal and compliance & ethics teams after having most recently been the Chief Legal Officer for the Broad Institute of MIT & Harvard.